Conditional distribution modeling as an alternative method for covariates simulation: Comparison with joint multivariate normal and bootstrap techniques

著者: Smania, Giovanni, Jonsson, E. Niclas
出版年 CPT Pharmacometrics Syst Pharmacol (2021)

Comparison of stepwise covariate model building strategies in population pharmacokinetic-pharmacodynamic analysis

著者: Wählby, Ulrika, Jonsson, E. Niclas, Karlsson, Mats O.
出版事項 2002

Nonlinearity detection: Advantages of nonlinear mixed-effects modeling

著者: Jonsson, E. Niclas, Karlsson, Mats O., Wade, Janet R.
出版事項 2000

A Physiologically-Based Pharmacokinetic Framework for Prediction of Drug Exposure in Malnourished Children

著者: Sjögren, Erik, Tarning, Joel, Barnes, Karen I., Jonsson, E. Niclas
出版年 Pharmaceutics (2021)

Randomized exposure-controlled trials; impact of randomization and analysis strategies

著者: Karlsson, Kristin E, Grahnén, Anders, Karlsson, Mats O, Jonsson, E Niclas
出版事項 2007

Population pharmacokinetics of tanezumab in phase 3 clinical trials for osteoarthritis pain

著者: Jonsson, E. Niclas, Xie, Rujia, Marshall, Scott F., Arends, Rosalin H.
出版年 Br J Clin Pharmacol (2016)

A Bayesian decision support tool for efficient dose individualization of warfarin in adults and children

著者: Hamberg, Anna-Karin, Hellman, Jacob, Dahlberg, Jonny, Jonsson, E Niclas, Wadelius, Mia
出版年 BMC Med Inform Decis Mak (2015)

Population pharmacokinetics of levosimendan in patients with congestive heart failure

著者: Jonsson, E Niclas, Antila, Saila, McFadyen, Lynn, Lehtonen, Lasse, Karlsson, Mats O
出版事項 2003

A Fast Method for Testing Covariates in Population PK/PD Models

著者: Khandelwal, Akash, Harling, Kajsa, Jonsson, E. Niclas, Hooker, Andrew C., Karlsson, Mats O.
出版事項 2011

Characterizing variability in warfarin dose requirements in children using modelling and simulation

著者: Hamberg, Anna-Karin, Wadelius, Mia, Friberg, Lena E, Biss, Tina T, Kamali, Farhad, Jonsson, E Niclas
出版事項 2014

Population pharmacokinetics of clomethiazole and its effect on the natural course of sedation in acute stroke patients

著者: Zingmark, Per-Henrik, Ekblom, Marianne, Odergren, Tomas, Ashwood, Tim, Lyden, Patrick, Karlsson, Mats O, Jonsson, E Niclas
出版事項 2003

Modeling Disease Progression in Acute Stroke Using Clinical Assessment Scales

著者: Karlsson, Kristin E., Wilkins, Justin J., Jonsson, Fredrik, Zingmark, Per-Henrik, Karlsson, Mats O., Jonsson, E. Niclas
出版事項 2010

Population pharmacokinetic/pharmacodynamic (PK/PD) modelling of the hypothalamic–pituitary–gonadal axis following treatment with GnRH analogues

著者: Tornøe, Christoffer W, Agersø, Henrik, Senderovitz, Thomas, Nielsen, Henrik A, Madsen, Henrik, Karlsson, Mats O, Jonsson, E Niclas
出版事項 2007

A PK/PD Analysis of Circulating Biomarkers and Their Relationship to Tumor Response in Atezolizumab‐Treated non‐small Cell Lung Cancer Patients

著者: Netterberg, Ida, Li, Chi‐Chung, Molinero, Luciana, Budha, Nageshwar, Sukumaran, Siddharth, Stroh, Mark, Jonsson, E. Niclas, Friberg, Lena E.
出版年 Clin Pharmacol Ther (2018)

Warfarin dose prediction in children using pharmacometric bridging—comparison with published pharmacogenetic dosing algorithms

著者: Hamberg, Anna-Karin, Friberg, Lena E., Hanséus, Katarina, Ekman-Joelsson, Britt-Marie, Sunnegårdh, Jan, Jonzon, Anders, Lundell, Bo, Jonsson, E. Niclas, Wadelius, Mia
出版事項 2013

Erratum to: Warfarin dose prediction in children using pharmacometric bridging – comparison with published pharmacogenetic dosing algorithms

著者: Hamberg, Anna-Karin, Friberg, Lena E., Hanséus, Katarina, Ekman-Joelsson, Britt-Marie, Sunnegårdh, Jan, Jonzon, Anders, Lundell, Bo, Jonsson, E. Niclas, Wadelius, Mia
出版事項 2013